This transgenic mouse has a Tet response element upstream of a human c-Abl 1b isoform modified to harbor two amino acid substitutions (P242E/P249E) in the conserved proline residues of the SH2-SH3 linker region that render the protein constitutively active (AblPP). Expression may be contoled via the Tet-Off/Tet-On system for use in studies related to tau phosphorylation.
Peter Davies, Albert Einstein College of Medicine
Genetic Background | Generation |
---|---|
|
Allele Type |
---|
Transgenic (Inducible, Constitutively active, Inserted expressed sequence, Humanized sequence) |
Hemizygous AblPP transgenic mice are viable and fertile with no reported phenotypic abnormalities. The TRE-AblPP transgene has the Tet response element (TRE or tetO) upstream of a human c-Abl 1b isoform modified to harbor two amino acid substitutions (P242E/P249E) in the conserved proline residues of the SH2-SH3 linker region that render the protein constitutively active (AblPP). When bred with other mice expressing tetracycline-controlled transactivator protein (tTA) or reverse tetracycline-controlled transactivator protein (rtTA), AblPP expression in the resulting double mutant offspring can be regulated with tetracycline or its analog doxycycline (dox). As designed, AblPP transgenic mice have no reported levels of AblPP expression in the absence of tTA.
These AblPP transgenic mice allow Tet-Off/Tet-On expression of a constitutively active form of c-Abl, and may be may be useful for studying tau phosphorylation and the pathogenesis of neurodegeneration/neuroinflammation associated with Alzheimer's disease. For example, when bred to a strain expressing tTA in forebrain neurons (Stock No. 007004), the resulting AblPP/tTA double mutant mice develop early reactive gliosis and astrocyctosis that continues to a severe, progressive neurodegeneration in the CA1 region of the hippocampus. Such double mutant mice will be available as Stock No. 015838.
The TRE-AblPP transgene was designed with a Tet response element (TRE) followed by a constitutively active c-Abl sequence (AblPP) and a beta-globin polyA sequence. The Tet response element (TRE) contains seven copies of the 42-bp tet operator sequence (tetO) just upstream of a minimal CMV promoter. To generate the AblPP sequence, a cDNA sequence encoding the nuclear-localizing isoform (1b) of the human c-Abl (ABL1; c-abl oncogene 1, non-receptor tyrosine kinase) was modified via site-directed mutagenesis to change the conserved proline residues of the SH2-SH3 linker region to glutamate (P242E/P249E). The 5.4 kb TRE-AblPP transgene was injected into the embryos of FVB/NTac mice. Founder mice were bred with FVB/NTac mice to establish founder line C. The colony was then maintained for several generations by breeding TRE-AblPP females with CaMKIIa-tTA males (on a C57BL/6 genetic background; see Stock No. 007004). During this time, two generations of backcrossing TRE-AblPP males with C57BL/6J females are also reported. TRE-AblPP transgenic mice (not harboring the Camk2a-tTA transgene) on a mixed C57BL/6J;FVB/N genetic background were sent to The Jackson Laboratory Repository (see SNP note below). Upon arrival, TRE-AblPP transgenic mice were bred to C57BL/6J inbred mice (Stock No. 000664) for at least one generation to establish the colony.
A 27 SNP (single nucleotide polymorphism) panel analysis covering all 19 chromosomes and the X chromosome was performed on the rederived living colony at The Jackson Laboratory Repository. 13 of 27 markers (representing 12 different chromosomes) were found to be segregating for allele-type other than C57BL/6. Ten of these 13 markers had the allele-type shared by FVB/NJ and CBA/J. The other three markers (one each on chromosomes 5, 11, and 16) were neither C57BL/6J nor FVB/NJ allele-type, and had the allele-type shared by CBA/J. Taken with the strain development history, these data suggest the mice sent to The Jackson Laboratory Repository are a mix of C57BL/6 and FVB/N, with some remaining CBA genomic contributions left over from the CaMKIIa-tTA breedings.
Expressed Gene | ABL1, ABL proto-oncogene 1, non-receptor tyrosine kinase, human |
---|---|
Site of Expression | In the absence of dox (off-dox), AblPP/tTA mice exhibit forebrain-specific neuronal expression of the constitutively active AblPP. No significant AblPP expression is observed in the cerebellum or brainstem (with or without dox). Greatly increased c-Abl kinase activity (20- to 30-fold) and increased c-Abl phosphorylation at tyrosine 412 is observed in the forebrain of AblPP/tTA mice off-dox compared to control mice. AblPP/tTA mice exhibit substantial microgliosis (beginning ~3 weeks off-dox) and astrocyctosis (beginning ~6-9 weeks off-dox). |
Allele Name | transgene insertion C, Peter Davies |
---|---|
Allele Type | Transgenic (Inducible, Constitutively active, Inserted expressed sequence, Humanized sequence) |
Allele Synonym(s) | AblPP; c-AblPP; TRE-AblPP; TRE-c-AblPP |
Gene Symbol and Name | Tg(tetO-ABL1*P242E*P249E)CPdav, transgene insertion C, Peter Davies |
Gene Synonym(s) | |
Promoter | tetO, tet operator, |
Expressed Gene | ABL1, ABL proto-oncogene 1, non-receptor tyrosine kinase, human |
Site of Expression | In the absence of dox (off-dox), AblPP/tTA mice exhibit forebrain-specific neuronal expression of the constitutively active AblPP. No significant AblPP expression is observed in the cerebellum or brainstem (with or without dox). Greatly increased c-Abl kinase activity (20- to 30-fold) and increased c-Abl phosphorylation at tyrosine 412 is observed in the forebrain of AblPP/tTA mice off-dox compared to control mice. AblPP/tTA mice exhibit substantial microgliosis (beginning ~3 weeks off-dox) and astrocyctosis (beginning ~6-9 weeks off-dox). |
Strain of Origin | FVB/NTac |
Chromosome | UN |
Molecular Note | The TRE-AblPP transgene was designed with a Tet response element (TRE) followed by a constitutively active c-Abl sequence (AblPP) and a beta-globin polyA sequence. The Tet response element (TRE) contains seven copies of the 42-bp tet operator sequence (tetO) just upstream of a minimal CMV promoter. To generate the AblPP sequence, a cDNA sequence encoding the nuclear-localizing isoform (1b) of the human c-Abl (ABL1; c-abl oncogene 1, non-receptor tyrosine kinase) was modified via site-directed mutagenesis to change the conserved proline residues of the SH2-SH3 linker region to glutamate (P242E/P249E). |
Mutations Made By | Peter Davies, Albert Einstein College of Medicine |
When maintaining a live colony, transgene carrier mice may be bred together or to wildtype (noncarrier) mice from the colony. The donating investigator reports they have not tried to generate homozygous mice.
When using the STOCK Tg(tetO-ABL1*P242E*P249E)CPdav/J mouse strain in a publication, please cite the originating article(s) and include JAX stock #014544 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Hemizygous or Non carrier forTg(tetO-ABL1*P242E*P249E)CPdav |
Frozen Mouse Embryo | STOCK Tg(tetO-ABL1*P242E*P249E)CPdav/J Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | STOCK Tg(tetO-ABL1*P242E*P249E)CPdav/J Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | STOCK Tg(tetO-ABL1*P242E*P249E)CPdav/J Frozen Embryo | $3373.50 |
Frozen Mouse Embryo | STOCK Tg(tetO-ABL1*P242E*P249E)CPdav/J Frozen Embryo | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.